Acutaas Chemicals Ltd vs Fredun Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 17, 2026

Key Highlights

The Latest Trading Price of Acutaas Chemicals Ltd is ₹ 2730 as of 15 May 15:30 . The P/E Ratio of Acutaas Chemicals Ltd changed from 125.9 on March 2025 to 94.3 on March 2024 . This represents a CAGR of -5.62% over 5 yearsThe P/E Ratio of Fredun Pharmaceuticals Ltd changed from 16 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years The Market Cap of Acutaas Chemicals Ltd changed from ₹ 9994 crore on March 2025 to ₹ 4036 crore on March 2024 . This represents a CAGR of -16.59% over 5 yearsThe Market Cap of Fredun Pharmaceuticals Ltd changed from ₹ 315.67 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of Acutaas Chemicals Ltd for the Mar '26 is ₹ 443.86 crore as compare to the Dec '25 revenue of ₹ 397.88 crore. This represent the growth of 11.56% The revenue of Fredun Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 160.92 crore. This represent the decline of -100% The ebitda of Acutaas Chemicals Ltd for the Mar '26 is ₹ 194.62 crore as compare to the Dec '25 ebitda of ₹ 155.35 crore. This represent the growth of 25.28% The ebitda of Fredun Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 26.34 crore. This represent the decline of -100% The net profit of Acutaas Chemicals Ltd changed from ₹ 14.69 crore to ₹ 134.28 crore over 8 quarters. This represents a CAGR of 202.34% The net profit of Fredun Pharmaceuticals Ltd changed from ₹ 13.74 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The Dividend Payout of Acutaas Chemicals Ltd changed from 15.19 % on March 2022 to 7.7 % on March 2025 . This represents a CAGR of -15.62% over 4 yearsThe Dividend Payout of Fredun Pharmaceuticals Ltd changed from 13.9 % on March 2021 to 1.59 % on March 2025 . This represents a CAGR of -35.18% over 5 years .

About Acutaas Chemicals Ltd

Acutaas Chemicals Limited was initially formed as partnership firm in the name of 'Ami Organics' on 3 January, 2004 at Surat, India.
The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
Subsequently, the Company was converted into a Public Limited Company, reflecting the change in name of the Company to 'Ami Organics Limited' on April 18, 2018.
The name of the Company has now changed to Acutaas Chemicals Limited with effect from May 15, 2025, pursuant to the receipt of Fresh Certificate of Incorporation from the Registrar of Companies. The Company is engaged in business of drugs intermediate chemicals and related activities.
The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94.
The Company was promoted by Nariman Medhora and Daulat N Medhora.
The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

FAQs for the comparison of Acutaas Chemicals Ltd and Fredun Pharmaceuticals Ltd

Which company has a larger market capitalization, Acutaas Chemicals Ltd or Fredun Pharmaceuticals Ltd?

Market cap of Acutaas Chemicals Ltd is 22,357 Cr while Market cap of Fredun Pharmaceuticals Ltd is 1,304 Cr

What are the key factors driving the stock performance of Acutaas Chemicals Ltd and Fredun Pharmaceuticals Ltd?

The stock performance of Acutaas Chemicals Ltd and Fredun Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Acutaas Chemicals Ltd and Fredun Pharmaceuticals Ltd?

As of May 17, 2026, the Acutaas Chemicals Ltd stock price is INR ₹2730.8. On the other hand, Fredun Pharmaceuticals Ltd stock price is INR ₹2366.45.

How do dividend payouts of Acutaas Chemicals Ltd and Fredun Pharmaceuticals Ltd compare?

To compare the dividend payouts of Acutaas Chemicals Ltd and Fredun Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.